OPINON: OCT vs. IVUS Guided PCI

Original Title: Optical frequency domain imaging vs. IVUS in PCI: the OPINION trial – one-year primary endpoint results.
Presenter: T. Kubo.

 

Optical coherence tomography (OCT) is increasingly being used in the daily practice given its greater capacity to define anatomical structures vs. intravascular ultrasound (IVUS). The clinical impact of this decision remains unclear.

 
This study was designed as non-inferiority; 800 patients were randomized 1:1 to OCT guided PCI vs. IVUS guided PCI, and they all received the Nobori DES.

 
Angiographic follow up was at 8 and 12 months. Primary end point was target vessel failure (combination of cardiovascular death, target vessel infarction and clinically justified target vessel revascularization).

 
There were no differences between the groups in procedural success rate, stent diameter or total number of stents. Primary end point incidence was 5.2% for the OCT group and 4.9% for the IVUS group (p<0.05 for non-inferiority). As regards primary end point component rates, separately, no differences were found.

 

Conclusion
OCT guided PCI vs. IVUS guided PCI showed similar clinical and angiographic events at 12 months. In both groups, death and target vessel infarction incidence were extremely low.

opinion

More articles by this author

TAVI at 10 Years: First Study to Assess TAVI Long Term Durability

Original Title: First look at long-term durability of transcatheter heart valves: Assessment of valve function up to 10 years after implantation. Presenter: Danny Dvir.   Transcatheter aortic...

LEADERS FREE ACS: Biolimus coated stent vs. bare metal stent in ACS with high bleeding risk

Original Title: Biolimus A9 drug-coated stent vs. bare metal stent in patients presenting with ACS. A pre-specified LEADERS FREE ACS sub-study. Presenter: C.K. Naber.   In ACS...

FANTOM II: New sirolimus eluting bioresorbable scaffold

Original Title: Fantom sirolimus-eluting BRS – FANTOM II Trial. Presenter: Alexandre Abizaid   This new sirolimus eluting bioresorbable scaffold is the only one which can be directly...

EWOLUTION: Outcomes of left atrial appendage closure in the real world

Original Title: EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe. Presenter: Martin Bergmann.   This study presented the experience of left...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....